Share.

    5 Kommentare

    1. Non-hallucinogenic psychedelics are being explored as the new frontier of psychiatric treatment, although there is still an ongoing debate whether the hallucinogenic effect is required for the antidepressant effect. Scientists have made a groundbreaking discovery in psychedelic research by identifying distinct neural circuits responsible for the therapeutic and hallucinogenic effects of psychedelic drugs. Using a mouse model and the drug 2,5-dimethoxy-4-iodoamphetamine (DOI), researchers were able to separate the anti-anxiety properties from the hallucinogenic side effects.

    2. Carbonbased666 on

      That’s called microdosing Lol .people dont need new shit nature have all.. just know how to use the right dosage and that’s all …but big pharma dont want to lose money that’s all the deal

    3. The hallucinogenic effects are where a lot of the therapeutic benefit comes from. Having a heart to heart with your dead parent is a cathartic experience.

    4. Really_McNamington on

      Plus all that juicy, juicy patentability, can’t forget about that. (It’s entirely the reason.)

    5. If they’re correct, and after thousands of people benefit from this without side effects, I’ll definitely try it out. I know too many people who would benefit from this.

      I got a lot of progress from the disassociative properties of psilocybin(I wonder if that’s part of the hallucination aspect that they’re blocking).

      I finally got to see myself without my ego and biases getting in the way. It helped me get away from the lies my ego tells myself.

      Seeing myself for what I truly am helped me push myself to overcome a lot of unresolved issues, and I’m much better for it.

    Leave A Reply